Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 
Category: Nephrology | Oncology | Pathology | Pharmacy | Surgery | Journal

Back to Journal Articles

Conditioning Regimen Beneficial for Kidney Recipients

Last Updated: March 28, 2012.

 

Lymphoid irradiation, antithymocyte globulin help wean patients from immunosuppressive drugs

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Following a conditioning regimen of lymphoid irradiation and antithymocyte globulin, the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.

WEDNESDAY, March 28 (HealthDay News) -- Following a conditioning regimen of lymphoid irradiation (TLI) and antithymocyte globulin (ATG), the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.

In a tolerance induction protocol, John D. Scandling, M.D., of the Stanford University School of Medicine in California, and colleagues studied 16 patients conditioned with TLI and ATG who were given kidney transplants and an injection of CD34+ hematopoietic progenitor cells and T cells from human leukocyte antigen-matched donors. Changes in chimerism, the balance of T-cell subsets, and responses to donor alloantigens were monitored.

The researchers found that 15 patients developed multilineage chimerism without graft-versus-host disease. In eight patients with chimerism for at least six months, antirejection medications were withdrawn for one to three years (mean, 28 months) without subsequent episodes of rejection. Drug withdrawal was occurring or had just occurred for four chimeric patients, and four patients experienced return of underlying disease or rejection episodes and consequently were not withdrawn. Compared with conventional naive CD4+ T cells, early high ratios of CD4+CD25+ regulatory T cells and natural killer T cells were seen in blood cells from all patients. Patients who were off drugs demonstrated specific unresponsiveness to alloantigens from donors.

"TLI and ATG promoted the development of persistent chimerism and tolerance in a cohort of patients given kidney transplants and hematopoietic donor cell infusions," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Omontys Approved for Anemia in Kidney Disease Patients Next: Extended-Release Niacin Raises Fasting Glucose Levels

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.